ClinOps Revenue and Competitors
Estimated Revenue & Valuation
- ClinOps's estimated annual revenue is currently $3.7M per year.
- ClinOps's estimated revenue per employee is $155,000
Employee Data
- ClinOps has 24 Employees.
- ClinOps grew their employee count by 4% last year.
ClinOps's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Human Resourse Administrator | Reveal Email/Phone |
ClinOps Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $9.1M | 59 | -9% | N/A | N/A |
#10 | $16.6M | 107 | 3% | N/A | N/A |
What Is ClinOps?
ClinOps is a full service contract research organization for biotech, pharmaceutical and medical device companies. Unlike the large CROs, we are a streamlined organization that ensures immediate customer response and the flexibility to make adjustments rapidly, providing consistent quality and the first-hand attention from a senior, experienced team. We believe this paradigm allows us to provide our customers with a level of service that is flexible, efficient and sustainable for the delivery of a portfolio of clinical trials. We strive to establish synergies and team chemistry, and develop successful relationships that consists of a shared vision, mutual trust, and complementary expertise. ClinOps focuses on understanding and fulfilling our customers' needs and delivering top-quality results within aggressive timelines.
keywords:N/AN/A
Total Funding
24
Number of Employees
$3.7M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.5M | 24 | -4% | N/A |
#2 | $3.5M | 24 | -14% | N/A |
#3 | $5.1M | 24 | -38% | N/A |
#4 | $2.4M | 24 | N/A | N/A |
#5 | $2.4M | 24 | N/A | N/A |
